Method for estimating energy supply ratio based on glucose and ketone body, and related method and apparatus
By establishing a metabolic model and combining it with the measurement of blood glucose and blood ketone concentrations, the problems of expensive equipment and complicated operation in existing technologies have been solved, and convenient and accurate energy supply ratio estimation has been achieved, which is suitable for daily activity scenarios.
Patent Information
- Application Number
- CN202511239437.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-09-01
- Publication Date
- 2025-12-16
Smart Images

Figure CN121148683A_ABST
Abstract
Description
Technical Field
[0001] This disclosure relates to health-related information systems, and in particular to a method and related methods and apparatus for estimating the proportion of energy supply based on glucose and ketone bodies. Background Technology
[0002] Identifying the energy ratio of glucose to fat is crucial for developing weight loss programs and managing energy metabolism in patients with metabolic diseases such as diabetes. This energy ratio directly reflects the body's metabolic preferences and is an important basis for assessing metabolic health.
[0003] Currently, one type of method for estimating the energy supply ratio using existing technology is the direct measurement method based on gas metabolism analysis. Specifically, the energy supply ratio is estimated by collecting the exhaled gas of the subject and calculating the respiratory quotient (RQ). The basic principle is that the ratio of oxygen required to burn sugar and the ratio of carbon dioxide produced to burn fat are different, and the energy supply ratio is estimated by analyzing the ratio of oxygen and carbon dioxide in the subject's exhaled gas.
[0004] However, while direct measurement methods offer high accuracy, they rely on expensive equipment, complex procedures, and stringent environmental requirements, such as requiring subjects to wear masks and remain almost completely still. Therefore, they cannot be applied to everyday scenarios. Summary of the Invention
[0005] This disclosure is made in view of the above-mentioned situation, and its purpose is to provide a new method and related methods and apparatus for estimating energy supply ratio based on glucose and ketone bodies, which can estimate the energy supply ratio and improve the convenience of estimating the energy supply ratio.
[0006] Therefore, a first aspect of this disclosure provides a method for estimating the energy supply ratio based on glucose and ketone bodies, comprising: establishing a metabolic model based on a target metabolic pathway, the target metabolic pathway including a first pathway representing the conversion of glucose and fat into ATP, the metabolic model being used to represent the relationship between multiple target metabolites associated with the target metabolic pathway; acquiring and measuring glucose concentration and ketone body concentration, the measured glucose concentration and the measured ketone body concentration representing the blood glucose concentration and ketone body concentration in different tissues distributed by the target metabolic pathway, respectively, the multiple target metabolites including blood glucose and ketone bodies; estimating the concentration of a first portion of the multiple target metabolites based on the measured glucose concentration, the measured ketone body concentration and the metabolic model, the first portion of the multiple target metabolites being target metabolites other than ATP in the first pathway; and determining the energy supply ratio of glucose and fat based on the concentration of the first portion of the multiple target metabolites. In this case, estimating the energy supply ratio based on the measured glucose concentration and the measured ketone body concentration can improve the convenience of estimating the energy supply ratio. In addition, it also facilitates the real-time tracking of the concentration of target metabolites in the human body's energy metabolism system. In addition, choosing blood glucose and blood ketones as known values can improve the convenience of data collection. Furthermore, the two are affected differently by external factors (such as food). Combining the two can simultaneously consider the response speed of the metabolic model and the accuracy and stability of estimating the target metabolite.
[0007] Additionally, in the method according to the first aspect of this disclosure, optionally, the metabolic model is a kinetic model, where the concentration of the second portion, including the first portion, of the plurality of target metabolites is defined as a plurality of state variables of the metabolic model, each state variable representing the concentration of a target metabolite; the plurality of state variables are evolved based on the metabolic model to estimate the concentration of the second portion of the plurality of target metabolites, thereby obtaining the concentration of the first portion of the plurality of target metabolites, wherein the measured glucose concentration is used as input to drive the evolution of the plurality of state variables, and the measured ketone body concentration is used as a response to calibrate the evolution of the plurality of state variables. In this case, using blood glucose as the driver can reduce the introduction of unnecessary complexity. Furthermore, the state changes driven by blood glucose concentration are simulated data, and since the model itself may not be accurate enough or the parameters may not be accurate enough, the simulated data may not be correct. Using blood ketone concentration as a response provides a window to observe whether the evolution process is accurate. Thus, the concentration of the target metabolite can be inferred. In addition, blood glucose is greatly affected by external factors (such as food), while blood ketones are generally not affected by external factors under normal circumstances. Using glucose concentration as input can enable metabolic models to respond quickly to dynamic changes, and using ketone body concentration as response can improve the accuracy and stability of estimating target metabolites.
[0008] Furthermore, in the method according to the first aspect of this disclosure, optionally, an initial state vector is created, the initial state vector including initial values of the plurality of state variables; based on the initial state vector, the metabolic model is simulated to obtain an evolutionary state vector by inputting the initial state vector and the measured glucose concentration; based on the measured ketone body concentration, the evolutionary state vector is calibrated using a Kalman filter, wherein the measured value of the Kalman filter is the measured ketone body concentration, and the predicted value of the Kalman filter is the estimated blood ketone body concentration based on the evolutionary state vector. This improves the ease of calibration.
[0009] Additionally, in the method according to the first aspect of this disclosure, optionally, the metabolic model includes multiple differential kinetic equations, each representing the rate of change of a target metabolite and established based on the relationship, and each differential kinetic equation is linear; each differential kinetic equation includes multiple terms that increase and / or decrease the rate of change of the target metabolite, wherein, in response to the relationship between the rate of change of the target metabolite and blood glucose, the multiple terms include terms related to the measured glucose concentration, and in response to the conversion relationship between the target metabolite and ATP, the multiple terms include a decreasing term related to the energy supply of the target metabolite. In this case, the multiple terms including terms related to the measured glucose concentration can take blood glucose as input and evolve the state variable over time. Additionally, the multiple terms including the decreasing term related to the energy supply of the target metabolite can reflect the change in the rate of change of the target metabolite caused by energy supply. Furthermore, the linearity of each differential kinetic equation simplifies the metabolic model.
[0010] Additionally, in the method according to the first aspect of this disclosure, optionally, the value of the reduction term related to the energy supply of the target metabolite in the corresponding differential kinetic equation is determined based on the concentration of the first portion of the plurality of target metabolites, and the consumption rate is taken as the rate at which the target metabolite is converted into ATP; the energy supply ratio is determined based on the ratio of the rate of glucose consumption to the rate of consumption of the target metabolite considered as fat.
[0011] Additionally, in the method according to the first aspect of this disclosure, optionally, the target metabolites considered as fat include ketone bodies in the blood and free fatty acids in muscle, and the consumption rate of the target metabolites considered as fat is the sum of the consumption rates of ketone bodies in the blood and free fatty acids in muscle. In this case, simultaneously considering the consumption rates of blood ketone bodies and free fatty acids in muscle can improve the accuracy of estimating the rate of fat consumption.
[0012] Additionally, in the method according to the first aspect of this disclosure, optionally, the different tissues also include at least one of liver, muscle, fat cells and brain cells, and the plurality of state variables include at least one of liver glycogen, liver free fatty acids, liver triglycerides, blood free fatty acids, blood ketones, blood triglycerides, muscle glycogen, muscle glucose, muscle free fatty acids, muscle triglycerides and insulin in the body.
[0013] A second aspect of this disclosure provides a method for determining the fat-burning rate based on glucose and ketone bodies, comprising: determining the energy supply ratio at a single time point according to the method of the first aspect of this disclosure; and determining the fat-burning rate based on a plurality of total energy consumptions at a plurality of time points and a plurality of energy supply ratios at the plurality of time points.
[0014] Additionally, in the method according to the second aspect of this disclosure, optionally, the plurality of time points includes a first time point and a second time point, and determining the fat-burning rate includes: determining the fat mass at the first time point based on the total energy consumed at the first time point and the energy supply ratio at the first time point; determining the fat mass at the second time point based on the total energy consumed at the second time point and the energy supply ratio at the second time point; and determining the fat-burning rate based on the fat mass at the first time point, the fat mass at the second time point, and the time difference between the first time point and the second time point.
[0015] A third aspect of this disclosure provides an electronic device including a processor and a memory, the memory storing a computer program that, when executed, implements the methods as described in the first aspect of this disclosure or the methods described in the second aspect of this disclosure.
[0016] According to this disclosure, a method and related methods and apparatus for estimating energy supply ratio based on glucose and ketone bodies are provided, which can improve the convenience of estimating energy supply ratio. Attached Figure Description
[0017] This disclosure will now be explained in further detail by way of example only with reference to the accompanying drawings.
[0018] Figure 1 This is a schematic diagram illustrating a monitoring environment for simultaneously monitoring glucose and ketone body concentrations as described in this disclosure example.
[0019] Figure 2 This is a schematic diagram illustrating the control device involved in the example of this disclosure.
[0020] Figure 3 This is an exemplary flowchart illustrating the estimation method involved in the examples of this disclosure.
[0021] Figure 4This is a schematic diagram illustrating the target metabolic pathway involved in the examples of this disclosure.
[0022] Figure 5 This is an exemplary flowchart illustrating the evolution of multiple state variables based on the measurement of ketone body concentration and the use of Kalman filtering, as described in this disclosure.
[0023] Figure 6 This is an exemplary flowchart illustrating the determination method involved in the examples of this disclosure.
[0024] Figure 7 This is an exemplary flowchart illustrating the determination of fat-burning rate as described in this disclosure.
[0025] Figure 8 This is an exemplary block diagram illustrating an electronic device to which the present disclosure relates. Detailed Implementation
[0026] Hereinafter, preferred embodiments of the present disclosure will be described in detail with reference to the accompanying drawings. In the following description, the same reference numerals are used for the same components, and repeated descriptions are omitted. Furthermore, the drawings are merely schematic diagrams, and the proportions of the components or the shapes of the components may differ from actual figures. It should be noted that the terms "comprising" and "having," and any variations thereof, in this disclosure, do not necessarily limit the process, method, system, product, or apparatus to the explicitly listed steps or units, but may include or have other steps or units not explicitly listed or inherent to these processes, methods, products, or apparatuses.
[0027] First, let me introduce the relevant terminology used in this disclosure.
[0028] ATP (Adenosine Triphosphate) is a molecule that directly provides energy within cells and is an energy substance.
[0029] "Fat burning rate" can refer to the speed at which fat is consumed, or it can be called the fat burning rate. The fat burning rate tells you how many grams of fat are burned per unit of time (e.g., per hour). For example, how many grams of fat are burned per hour.
[0030] Ketone bodies can be a collective term for acetoacetic acid, β-hydroxybutyric acid, and acetone, intermediate products of fatty acid oxidation in the liver. In the examples of this disclosure, ketone bodies can be monitored by detecting any one or more of acetoacetic acid, β-hydroxybutyric acid, and acetone. That is, ketone bodies can be at least one of acetoacetic acid, β-hydroxybutyric acid, and acetone. Preferably, parameters related to ketone bodies can be obtained by monitoring β-hydroxybutyric acid. In this case, β-hydroxybutyric acid is more sensitive and representative in reflecting ketone body levels, which can improve the reliability of measuring ketone body concentration. In addition, ketone bodies in the blood can be simply referred to as blood ketones.
[0031] As mentioned above, existing methods rely on expensive equipment, complex operating procedures, and stringent requirements for the experimental environment. The inventors discovered that combining blood glucose (i.e., blood glucose) concentration with blood ketone concentration can estimate the energy supply ratio. Blood glucose and blood ketones are two important energy substances in the human energy metabolism system. When blood glucose levels are low and liver glycogen reserves are low, the body's energy metabolism system produces ketone bodies in the liver to provide energy for the brain. The production of ketone bodies also consumes fat, and the level of blood ketones can also indicate the rate of fat consumption. Therefore, it is evident that there is a connection between blood glucose and blood ketones and the energy supply from glucose and fat.
[0032] Therefore, the inventors have provided several solutions, and corresponding embodiments that can at least address some of the problems described above, thereby improving the ease of estimating energy supply ratios. Examples of this disclosure will be described in detail below.
[0033] The analyte monitoring system disclosed herein can be configured to continuously monitor analyte concentrations. In some examples, the analyte monitoring system may include a sensor control device (hereinafter referred to as the control device). The control device may be configured to acquire a signal related to the analyte concentration (hereinafter referred to as the analyte signal), process the analyte signal, and / or transmit information related to the analyte signal (hereinafter referred to as analyte information). Furthermore, the analyte signal can be any signal that corresponds to the analyte concentration, and the analyte signal can be converted into an analyte concentration.
[0034] This disclosure also relates to a method for estimating the energy supply ratio based on glucose and ketone bodies (hereinafter referred to as the estimation method), which improves the ease of estimating the energy supply ratio. Furthermore, the estimation method described in this disclosure may also be referred to as the estimation method.
[0035] For ease of description, the rate of change of the concentration of the target metabolite or the rate of change of the concentration of the target metabolite will be referred to simply as the rate of change of the target metabolite (i.e., "concentration" will be omitted). The target metabolite used in the calculation of the energy contribution ratio among multiple target metabolites is referred to as the first part of the target metabolites, and the target metabolite used as a state variable among multiple target metabolites is referred to as the second part of the target metabolites. Furthermore, some examples use the simultaneous monitoring of glucose and ketone body concentrations; however, this is not intended to limit this disclosure. Unless there is a contradiction, the relevant descriptions are equally applicable to any other monitoring method capable of obtaining continuous glucose and ketone body concentrations.
[0036] Examples of this disclosure will now be described in detail with reference to the accompanying drawings. Figure 1 This is a schematic diagram illustrating a monitoring environment for simultaneously monitoring glucose and ketone body concentrations as described in this disclosure example.
[0037] refer to Figure 1 The monitoring environment may include a control device 7. The control device 7 may be configured to acquire blood glucose and blood ketone signals (hereinafter referred to as analyte signals) of the target subject 6. Specifically, a portion of the control device 7 may be located on the body surface of the target subject 6, and another portion may be located under the skin of the target subject 6, thereby enabling the monitoring of blood glucose and blood ketones.
[0038] In some examples, the monitoring environment may also include a receiving device 9 that receives analyte signals from the control device 7, and the control device 7 may be coupled to the receiving device 9. In some examples, the receiving device 9 may be a device with a display unit.
[0039] In some examples, the monitoring environment may also include a processing device 1, which can be used to receive analyte signals and / or blood glucose and blood ketone concentrations determined from the analyte signals and execute various protocols (e.g., estimation methods) involved in the examples of this disclosure. This allows for convenient acquisition of energy supply ratio or information related to the energy supply ratio (e.g., real-time energy supply ratio can be obtained simply by wearing the control device 7). In some examples, the processing device 1 can receive analyte signals from the control device 7 or the receiving device 9.
[0040] In some examples, the processing device 1 may be independent of the control device 7 or the receiving device 9. Specifically, the processing device 1 may be a device located outside of the control device 7 or the receiving device 9 and communicatively connected to the control device 7 or the receiving device 9. For example, the processing device 1 may be a server or a dedicated device. In some examples, the processing device 1 may be integrated into the control device 7 or the receiving device 9.
[0041] Figure 2 This is a schematic diagram illustrating the control device 7 involved in the example of this disclosure.
[0042] refer to Figure 2 In some examples, the control device 7 may include an analyte sensor 71 and an electronic component 72. The analyte sensor 71 may be configured to generate a signal related to glucose concentration (hereinafter referred to as a first signal) and a signal related to ketone body concentration (hereinafter referred to as a second signal), respectively, and the electronic component 72 may be configured to receive the first signal and the second signal. In some examples, the analyte sensor 71 may be configured to be at least partially implanted subcutaneously in the target object 6. This allows at least a portion of the analyte sensor 71 to contact the subcutaneous fluid of the target object 6 to generate an analyte signal. In other examples, the analyte sensor 71 may not contact the subcutaneous fluid of the target object 6. For example, when the analyte sensor 71 is based on optical signal measurement, the analyte signal can be obtained without contact with the subcutaneous fluid of the target object 6 via an optical signal.
[0043] Figure 3 This is an exemplary flowchart illustrating the estimation method involved in the examples of this disclosure. Figure 4 This is a schematic diagram illustrating the target metabolic pathway involved in the examples of this disclosure. Wherein, Figure 4 The arrows in the diagram can represent relationships between target metabolites. If the target metabolites at both ends of the arrow are the same, it can be considered a transport relationship; otherwise, it can be considered a transformation relationship. Furthermore, the estimation method can be implemented by at least some components of the computing device. For example, the estimation method can be implemented by the processor of processing device 1.
[0044] In some examples, the estimation method can establish a metabolic model of the ATP-related metabolic pathway, treating the concentration of a portion of the multiple target metabolites related to the pathway (i.e., the concentration of the second portion) as unknowns, and the concentration of another portion of the multiple target metabolites related to the pathway as knowns, and then estimating the concentration of the first portion of the multiple target metabolites based on this. In some examples, the known values can be used partly as input to the metabolic model and partly as the response of the metabolic model. The ATP-related metabolic pathway will be referred to as the target metabolic pathway below, and the estimation method will be described in detail with reference to the accompanying figures.
[0045] Furthermore, the target metabolic pathway can be correlated with the final metric that needs to be calculated (e.g., energy contribution ratio). In some examples, reference... Figure 4 The target metabolic pathway may include a first pathway D1 representing the conversion of glucose and fat into ATP. This allows for the subsequent calculation of the energy supply ratio of glucose and fat. In other words, when it is necessary to determine the energy supply ratio of glucose and fat, multiple target metabolites may be included that are converted into ATP and used to represent the target metabolites of glucose and fat. In some examples, the first pathway D1 may include a first sub-pathway representing the conversion of glucose into ATP and a second sub-pathway representing the conversion of fat into ATP.
[0046] In some examples, reference Figure 3 The estimation method may include establishing a metabolic model based on the target metabolic pathway, which represents the relationship between multiple target metabolites related to the target metabolic pathway (hereinafter referred to as the target relationship) (step S101); acquiring and measuring glucose concentration and ketone body concentration, which respectively represent the blood glucose concentration and ketone body concentration in different tissues where the target metabolic pathway is distributed (step S102); estimating the concentration of a first portion of the multiple target metabolites based on the measured glucose concentration, measured ketone body concentration, and the metabolic model (step S103); and determining the energy supply ratio of glucose and fat based on the concentration of the first portion of the multiple target metabolites (step S104). In this case, estimating the energy supply ratio based on the measured glucose concentration and measured ketone body concentration can improve the convenience of estimating the energy supply ratio. In addition, it is also convenient to track the concentration of target metabolites in the human body's energy metabolism system in real time. Furthermore, choosing blood glucose and blood ketones as known values can improve the convenience of data collection. On the other hand, the two are affected differently by external factors (such as food), and combining the two can simultaneously consider the response speed of the metabolic model and the accuracy and stability of estimating the target metabolites.
[0047] refer to Figure 3 As described above, in step S101, the metabolic model can be used to represent the target relationships among multiple target metabolites associated with the target metabolic pathway. Specifically, the target relationship is a relationship that can affect the rate of change of the target metabolite. Furthermore, the target metabolic pathway can be distributed in different tissues. Specifically, refer to... Figure 4 In different tissues where the target metabolic pathway is distributed, each tissue has its own compartment. Target metabolites in different tissue compartments influence each other, and target metabolites within the same tissue compartment also influence each other, thus affecting the rate of change of target metabolites. Metabolic models can be used to represent these influences. Therefore, target metabolites can be linked together through metabolic models.
[0048] Furthermore, the human metabolic pathway is complex. Through research, the inventors simplified the human metabolic pathway to obtain the target metabolic pathway. In some examples, references... Figure 4 The target metabolic pathway can be distributed in different tissues, including at least one of blood, liver, muscle, adipocytes, and brain cells. In this case, the metabolic model can be simplified, thereby reducing the difficulty of estimating the concentration of the target metabolite.
[0049] In addition, multiple target metabolites associated with the target metabolic pathway can be metabolites on the target metabolic pathway and metabolites that are not on the target metabolic pathway but affect the rate of change of metabolites on the target metabolic pathway (e.g., insulin in the body affects the rate of ketosis).
[0050] In some examples, multiple target metabolites associated with a target metabolic pathway may include glucose and ketone bodies (i.e., blood glucose and blood ketones) in the blood from different tissues where the target metabolic pathway is distributed. In some examples, multiple target metabolites may also include at least one of liver glycogen, liver free fatty acids, blood free fatty acids, muscle glycogen, muscle glucose, muscle free fatty acids, adipocyte free fatty acids, insulin, and ATP. That is, multiple target metabolites may include at least one of glycogen and free fatty acids in the liver, glucose, free fatty acids, and ketone bodies in the blood, glycogen, glucose, and free fatty acids in muscle, free fatty acids in adipocytes, insulin, and ATP. In this case, selecting these key metabolites simplifies the body's energy metabolism pathway (see [link to relevant documentation]). Figure 4 ).
[0051] In some examples, reference Figure 4 The multiple target metabolites associated with the target metabolic pathway may also include at least one of liver triglycerides, blood triglycerides, and muscle triglycerides. That is, the multiple target metabolites also include at least one of liver triglycerides, blood triglycerides, and muscle triglycerides.
[0052] In some examples, insulin in the body can be represented using insulin from the blood. This simplifies the metabolic model. In some examples, ATP can include ATP from brain cells and ATP from muscles. This also simplifies the metabolic model.
[0053] In some examples, the target relationship can include changes between target metabolites (i.e., the two can be converted). In some examples, references Figure 4The relationships between changes in multiple target metabolites can include at least one of the following: a relationship between liver glycogen and blood glucose; a relationship between liver free fatty acids and blood glucose; a relationship between liver free fatty acids and blood free fatty acids; a relationship between liver free fatty acids and blood ketones; a relationship between liver free fatty acids and liver triglycerides; a relationship between liver triglycerides and blood triglycerides; a relationship between blood glucose and muscle glucose; a relationship between blood free fatty acids and muscle free fatty acids; a relationship between blood free fatty acids and adipocyte free fatty acids; a relationship between blood ketones and ATP; a relationship between muscle glycogen and muscle glucose; a relationship between muscle glucose and ATP; a relationship between muscle free fatty acids and ATP; and a relationship between muscle free fatty acids and muscle triglycerides. Furthermore, the relationship between changes in liver free fatty acids and blood ketones can be simplified by considering the conversion of liver free fatty acids into ketone bodies in the liver before their diffusion into the bloodstream. This reduces the number of state variables in subsequent steps.
[0054] In some examples, the change relationship may include at least one of the transport relationship between similar target metabolites between different tissues and the transformation relationship between different types of target metabolites. Additionally, similar target metabolites, such as free fatty acids in the liver and free fatty acids in the blood, may simply be located in different tissues but are actually the same target metabolite.
[0055] For example, refer to Figure 4 Taking target metabolites in the liver as an example, there is a mutual conversion relationship between liver glycogen and blood glucose, a mutual conversion relationship between liver free fatty acids and blood glucose, a mutual transport relationship between liver free fatty acids and blood free fatty acids, a conversion relationship between liver free fatty acids and blood ketones, a conversion relationship between liver free fatty acids and liver triglycerides, and a transport relationship between liver triglycerides and blood triglycerides.
[0056] In some examples, the target relationship may also include an influence relationship, which may represent the effect on the rate of production of the target metabolite. In some examples, the influence relationship may include at least one of the influence relationship between blood glucose and the presence of insulin in the body (i.e., blood glucose concentration affects the rate of insulin secretion in the body) and the influence relationship between the presence of insulin in the body and the presence of blood ketones (i.e., insulin in the body affects the rate of ketosis).
[0057] Furthermore, the target relationship between the two target metabolites can be known (i.e., existing). That is, how one target metabolite affects the rate of change of another target metabolite within the target metabolic pathway can be known. For example, it can be determined based on existing research. This disclosure does not specifically limit the specific value or form of the target relationship.
[0058] In some examples, the target relationship may include a relationship coefficient, which can be used to represent the effect of the concentration of one target metabolite on the rate of change of another target metabolite. In some examples, the relationship coefficient multiplied by the concentration of one target metabolite can represent the amount of change in the rate of change of another target metabolite caused by the concentration of one target metabolite. In some examples, for the change relationship, the relationship coefficient may include the diffusion coefficient between similar target metabolites in different tissues and the conversion coefficient (also known as the reaction rate) between different classes of target metabolites.
[0059] Furthermore, the relationship coefficient can be a fixed value or a function of the concentration of the corresponding target metabolite affecting the relationship coefficient. In some examples, the relationship coefficient affected by intravenous insulin (i.e., the relationship coefficient can vary with intravenous insulin concentration) can be represented as a function based on intravenous insulin concentration. In some examples, the relationship coefficient affected by intravenous insulin may include the conversion coefficient between glucose and glycogen, the conversion coefficient of free fatty acids to ketone bodies (i.e., the coefficient related to the ketogenic rate), and the diffusion coefficient of free fatty acids transported from adipocytes to the bloodstream. In some examples, the relationship coefficient affected by blood glucose (i.e., the relationship coefficient can vary with blood glucose concentration) can be represented as a function based on blood glucose concentration. In some examples, the relationship coefficient affected by blood glucose may include a coefficient related to the rate of insulin production (also known as the secretion rate, which is a type of increase rate) in the body.
[0060] Furthermore, metabolic models can be any model capable of estimating the concentration of a target metabolite based on measurements of glucose concentration (e.g., machine learning models). In some examples, metabolic models can be machine learning models. In other examples, metabolic models can be kinetic models. This allows for a more accurate description of the human body's energy metabolism system.
[0061] In some examples, for kinetic models, the concentration of the second portion of multiple target metabolites can be represented as multiple state variables of the metabolic model. Each state variable can represent the concentration of a target metabolite (e.g., liver glycogen or free liver fatty acids), and the target metabolites in the second portion can include the target metabolites in the first portion. Thus, the concentration of the first portion can be obtained when the concentration of the second portion is obtained. Alternatively, the state variable can refer to the concentration of the target metabolite to be estimated using the metabolic model.
[0062] Furthermore, since measuring glucose concentration is subsequently used as input to the metabolic model and is already measured, measuring ketone body concentration is subsequently used as a response. Therefore, in some examples, the second part of a plurality of target metabolites can be selected from target metabolites other than blood glucose and includes blood ketones.
[0063] In some examples, during the selection process, for multiple target metabolites that are correlated, only one target metabolite can be retained. This further simplifies the metabolic model. For instance, the rate of increase of free fatty acids from adipocytes in the blood is a function related to the body's insulin concentration. The body's insulin concentration can be treated as a state variable, and the rate of increase can be represented using this function. In this case, the free fatty acids from adipocytes can be excluded from the state variable.
[0064] Furthermore, since ATP is the final energy source, its correlation with other target metabolites is not high. In some examples, the second part of multiple target metabolites may not include ATP (i.e., it is not considered a state variable). This allows for further simplification of the metabolic model.
[0065] In some examples, multiple state variables may include at least one of liver glycogen, liver free fatty acids, blood free fatty acids, blood ketones, muscle glycogen, muscle glucose, muscle free fatty acids, and insulin. In this case, these state variables are more concise compared to the metabolites of the body's energy metabolism system. Furthermore, including insulin facilitates adjustments for subsequent effects of insulin, improving the accuracy of estimating the target metabolite. In some examples, when considering changes in triglycerides, multiple state variables may include at least one of liver glycogen, liver free fatty acids, liver triglycerides, blood free fatty acids, blood ketones, blood triglycerides, muscle glycogen, muscle glucose, muscle free fatty acids, muscle triglycerides, and insulin. In this case, although the triglyceride concentration itself does not change as significantly, triglycerides have a conversion relationship with free fatty acids (see reference). Figure 4 Considering changes in triglycerides can further improve the accuracy of estimating target metabolites. In some examples, triglyceride concentration can be treated as a constant, thus simplifying the metabolic model.
[0066] In some examples, some relationship coefficients can also be treated as state variables. In this case, the relationship coefficients can be adjusted according to the individual, thereby improving accuracy.
[0067] In some examples, metabolic models may include multiple differential kinetic equations, each relating to a target metabolite (e.g., liver glycogen or free fatty acids). That is, building a metabolic model may involve establishing multiple differential kinetic equations. In this case, differential kinetic equations facilitate the description of target-based energy metabolism systems, thereby enabling the identification of the causes of state variable evolution and improving its interpretability.
[0068] In some examples, each differential kinetic equation can represent the rate of change of a target metabolite. That is, each differential kinetic equation can describe how a state variable or a measurement of glucose concentration affects the rate of change of the state (i.e., the concentration of the target metabolite).
[0069] In some examples, differential kinetic equations can be mapped one-to-one with state variables. That is, each state variable can correspond to a differential kinetic equation. For example, as mentioned above, if the second part of a plurality of target metabolites can be selected from target metabolites other than blood glucose and includes blood ketones, then the plurality of differential kinetic equations can exclude differential kinetic equations for blood glucose but include differential kinetic equations for blood ketones (i.e., constructing multiple differential kinetic equations for at least one other target metabolite besides blood glucose as input). For ease of description, some descriptions below refer to the target metabolite to which the state variable corresponding to the differential kinetic equation belongs as the current metabolite, and the other target metabolites in the differential kinetic equation as influencing metabolites.
[0070] As mentioned above, metabolic models are used to represent the target relationships among multiple target metabolites associated with a target metabolic pathway. In some examples, each differential kinetic equation can be based on the target relationship. That is, a differential kinetic equation can be established based on the target relationship to represent the rate of change of the target metabolite. In this case, the differential kinetic equation can reflect how the concentration of the target metabolite changes and how this change relates to other target metabolites, thereby linking different state variables.
[0071] In some examples, the parameters of each differential kinetic equation may include at least one relation coefficient determined by the target relation. This is specifically related to the factors affecting the rate of change of each target metabolite. For example, if the rate of change of a target metabolite is affected by blood glucose, its differential kinetic equation may include terms related to the measurement of glucose concentration.
[0072] Furthermore, each differential kinetic equation may include multiple terms that increase and / or decrease the rate of change of the current metabolite. The sum of these multiple terms represents the rate of change of the current metabolite. That is, each term may represent the rate of decrease or increase of the current metabolite in a given case, and the sum of these multiple terms represents the rate of change of the current metabolite. Specifically, appropriate terms may be selected to represent the rate of change of the corresponding target metabolite based on its metabolic pathway. In some examples, the multiple terms may include at least one of decrease and increase terms.
[0073] In some examples, in response to a target metabolite change rate and a target relationship with blood glucose (i.e., in response to the target metabolite change rate being affected by blood glucose), multiple terms can include terms related to the measured glucose concentration. That is, the measured glucose concentration can be used as input to the corresponding differential kinetic equation. Thus, blood glucose can be used as input to evolve the state variable over time. For example, a term related to the measured glucose concentration can be expressed as the corresponding relationship coefficient multiplied by the measured glucose concentration.
[0074] Furthermore, a decrease term can represent the rate of decrease of the current metabolite (i.e., the extent of the current metabolite decrease, also known as a negative term). Therefore, the mechanism of the current metabolite decrease can be described through the decrease term. For example, a decrease term can include terms corresponding to the rate of excretion of the current metabolite or the energy supply coefficient (i.e., the coefficient for conversion to ATP). In some examples, in response to the conversion relationship between the target metabolite and ATP (i.e., the target metabolite is converted into ATP), multiple terms can include decrease terms related to the energy supply of the target metabolite. Thus, the change in the rate of change of the target metabolite caused by energy supply can be reflected.
[0075] Furthermore, the increment term can represent the current rate of increase of metabolites (i.e., the current state of metabolite increase, also known as a positive term). Thus, the mechanism of current metabolite increase can be described through the increment term. For example, the increment term can be a diffusion coefficient from other tissues or a conversion coefficient affecting metabolite transformation.
[0076] Taking blood ketones as an example, the decreasing items can be those related to the energy supply of blood ketones, while the increasing items can be those related to the rate of ketosis.
[0077] In some examples, each differential kinetic equation can be linear. This simplifies the metabolic model. In some examples, the basic form of each differential kinetic equation can be: Where f represents the rate of change of the target metabolite as a function, S represents the state variable, and p represents the parameter. f is linear with respect to S.
[0078] In some examples, at least one of the terms in each differential kinetic equation can be represented as a product of a parameter and the concentration of the target metabolite. For a known concentration of the target metabolite, the parameter can be directly multiplied by the corresponding known value (e.g., a measured blood glucose concentration); for an unknown concentration of the target metabolite, the parameter can be multiplied by the corresponding state variable.
[0079] In some examples, at least one of the terms can be represented by a function. Taking insulin in the blood as an example, its corresponding differential kinetic equation can include its own emptying rate (also known as decay rate, which is a type of decrease rate) and the secretion rate of insulin secretion in the body affected by blood glucose (i.e., a type of increase rate), where the secretion rate can be a Hill function related to blood glucose concentration.
[0080] In some examples, the differential dynamic equations can take the form of: Among them, s i It is a state variable representing the concentration of a target metabolite (e.g., blood ketone concentration), -p j This represents the known parameters (i.e., relationship coefficients) associated with the reduction of the target metabolite. …
[0081] , This represents one to n known parameters (i.e., relationship coefficients) that are associated with an increase in the target metabolite. …
[0082] , Indicates with s i The concentrations of one to n target metabolites with target relationships (which can be known values, state variables, or represented by functions), where t represents time. Additionally, each term represents the rate of decrease of the target metabolite (e.g., -p). j s i ) or increase the rate (e.g.) ).
[0083] As mentioned above, in some examples, the relationship coefficient may be influenced by the target metabolite or there may be a correlation between the target metabolites. Therefore, some terms or parameters of the above formula may also be functions of the concentration of the target metabolite that has an effect or functions of the concentration of the target metabolite that has a correlation.
[0084] Taking blood ketones as an example, refer to Figure 4 Blood ketones are involved in the conversion into ATP (which is used by brain and muscle cells) and the conversion from free fatty acids in the liver. Therefore, the differential kinetic equation for blood ketones satisfies the following formula: Among them, s i -p is the state variable for blood ketone concentration. j Energy supply coefficient, This represents the conversion coefficient of free fatty acids in the liver to blood ketones. This represents the state variable of the concentration of free fatty acids in the liver. Additionally, -p j s i It can represent the rate of decrease in blood ketones (also known as the rate of consumption). It can represent the rate of increase of blood ketones (also known as the production rate or ketogenic rate).
[0085] In some examples, reference Figure 3 In step S102, the measurement of glucose concentration and ketone body concentration can be obtained continuously. That is, the measurement of glucose concentration and ketone body concentration can be continuous. This facilitates obtaining the energy supply ratio or other information obtained through the energy supply ratio over time. In some examples, the measurement of glucose concentration and ketone body concentration can be acquired by an analyte monitoring system.
[0086] In some examples, in subsequent processing, measuring glucose concentration can serve as input to a metabolic model to drive the evolution of multiple state variables, and measuring ketone body concentration can serve as a response to the metabolic model to calibrate the evolution of multiple state variables (described in detail later). In other examples, in step S102, the concentrations of at least two other target metabolites can also be measured and used as input and response, respectively. For example, the at least two other target metabolites can be any at least two target metabolites that can be measured in different tissues where the target metabolic pathway is distributed. Accordingly, unless there is a contradiction, the corresponding steps can be adaptively adjusted, for example, steps related to measuring glucose concentration and measuring ketone body concentration may not necessarily be involved.
[0087] In some examples, reference Figure 3 Step S103 is equivalent to estimating the concentration of the first portion of multiple target metabolites using a metabolic model representing the target relationship, given the known measured glucose concentration and ketone body concentration. This allows for tracking the state of the metabolic model.
[0088] In some examples, the concentration of the second part of multiple target metabolites can be estimated by evolving multiple state variables based on a metabolic model and combining the measurement of glucose concentration and the measurement of ketone body concentration (i.e., the known concentrations of glucose and ketone bodies in the blood). This yields the concentration of the first part of multiple target metabolites.
[0089] In some examples, combining glucose concentration measurements and ketone body concentration measurements can be used to: use glucose concentration measurements as input to drive the evolution of multiple state variables (i.e., glucose concentration measurements drive changes in the state variables of a metabolic model over time), and use ketone body concentration measurements as a response to calibrate the evolution of multiple state variables. In other words, blood glucose concentration is given (e.g., collected via a continuous glucose monitoring system), and other metabolites change depending on blood glucose concentration, with these changes calibrated by a given blood ketone concentration.
[0090] For skilled technicians, using blood glucose concentration as a driver is difficult to conceive of, as glucose itself is primarily driven by food or hormonal influences. In this case, using blood glucose as the driver reduces unnecessary complexity. Furthermore, state changes driven by blood glucose concentration are based on simulation data, which may not be accurate due to potential model inaccuracies or parameter deficiencies. Using blood ketone concentration as a response provides a window to observe the accuracy of the evolutionary process. That is, using blood ketone concentration as a response allows for continuous calibration by measuring ketone body concentration when the evolution deviates, thus enabling a relatively accurate estimation of the target metabolite concentration (i.e., making the estimated target metabolite concentration as close as possible to the true concentration; in other words, making the state estimate as close as possible to the actual situation). This allows for the inverse deduction of the target metabolite concentration. Additionally, blood glucose is greatly affected by external factors (such as food), while blood ketones are generally unaffected by external factors under normal circumstances. Using glucose concentration as input allows the metabolic model to respond quickly to dynamic changes, while using ketone body concentration as a response improves the accuracy and stability of target metabolite estimation.
[0091] Specifically, the initial state vector can be used as input to a metabolic model to simulate the evolution of multiple state variables, thereby obtaining an evolutionary state vector. Based on the evolutionary state vector, the concentration of the second part of multiple target metabolites can be determined. In the evolution, measuring glucose concentration can be used as input, and measuring ketone body concentration can be used as response.
[0092] Furthermore, the initial state vector can include initial values for multiple state variables. In some examples, the initial state vector (i.e., initial values) can be obtained using population data. For instance, the initial values can be set based on the general range of concentrations of the target metabolite in the population. The influence of the initial state vector decreases as blood glucose concentration is used as input.
[0093] Figure 5 This is an exemplary flowchart illustrating the evolution of multiple state variables based on the measurement of ketone body concentration and the use of Kalman filtering, as described in this disclosure.
[0094] In some examples, Kalman filtering can be used to calibrate the evolution of multiple state variables. The measured value from the Kalman filter can be the measured ketone body concentration, and the predicted value can be the estimated blood ketone body concentration based on the evolved state variables. This improves the ease of calibration. Kalman filtering is a statistically optimal method that combines measured and predicted values, calibrating multiple evolved state variables using the measured values. In some examples, Kalman filtering can include extended Kalman filtering and unscented Kalman filtering. This allows for consideration of the nonlinearity of the metabolic model itself.
[0095] Additionally, the estimated blood ketone body concentration can be referred to as the estimated ketone body concentration. In some examples, reference... Figure 5 The evolution based on measuring ketone body concentration and calibrating multiple state variables using Kalman filtering can include:
[0096] Step S201: Create an initial state vector. As described above, the initial state vector may include initial values for multiple state variables. For example, the initial state vector may be an array containing multiple elements, each element representing a state variable.
[0097] Step S202: Simulate the changes of multiple state variables in the metabolic model based on the initial state vector when the initial state vector is input and the ketone body concentration is measured to obtain the evolutionary state vector. That is, how the initial state vector of the metabolic model evolves given an initial state vector. For example, for a metabolic model that includes multiple differential kinetic equations, this is equivalent to solving differential kinetic equations.
[0098] Step S203: Based on the measured ketone body concentration, the evolutionary state vector is calibrated using Kalman filtering (i.e., the concentration of the target metabolite is extrapolated using Kalman filtering). The measured value of the Kalman filter can be the measured ketone body concentration, and the predicted value of the Kalman filter can be the estimated ketone body concentration obtained based on the evolutionary state vector. In Kalman filtering, comparing the estimated ketone body concentration with the measured ketone body concentration can identify whether there is any deviation in the evolution.
[0099] In some examples, the evolutionary state vector can be substituted into the metabolic model to determine the rate of change of blood ketones, and the estimated ketone body concentration can be obtained based on the rate of change of blood ketones.
[0100] As described above, in some examples, the metabolic model may include multiple differential kinetic equations, each representing the rate of change of a target metabolite. In this case, estimating the ketone body concentration based on the evolutionary state vector can include: estimating the blood ketone concentration at the time point where the glucose concentration was measured, based on the measured ketone body concentration and the rate of change of blood ketone determined by the evolutionary state vector and the differential kinetic equation (i.e., estimating the ketone body concentration). That is, the blood ketone concentration itself is a state variable, and the rate of change of blood ketone is itself a differential kinetic equation. Therefore, by inputting the evolutionary state vector into the differential kinetic equation, the estimated rate of change of blood ketone can be obtained. Based on the measured blood ketone concentration at the previous time point and the estimated rate of change of blood ketone, the blood ketone concentration at the next time point can be estimated. Comparing the estimated blood ketone concentration at the next time point with the measured blood ketone concentration at the corresponding time point can identify any deviations in the evolution. In this case, by predicting the blood ketone concentration, the blood ketone concentration is made as close as possible to the actual blood ketone concentration, thereby making the concentrations of other target metabolites as close as possible to the actual concentrations.
[0101] Furthermore, the first part of the multiple target metabolites can be the target metabolites that are converted into ATP. In some examples, the first part of the multiple target metabolites can be target metabolites other than ATP in the first pathway D1. This facilitates the subsequent calculation of the energy supply ratio of glucose and fat. In some examples, the first part of the multiple target metabolites can be related to the indicator to be calculated. For example, to calculate the energy supply ratio of glucose and fat, the second part can at least include, for example, glucose in muscle, blood ketones, and free fatty acids in muscle, which can be converted into ATP and are considered as target metabolites of glucose and fat.
[0102] In some examples, a reference is returned. Figure 3 In step S104, the energy supply ratio can refer to the proportion of glucose and fat converted into ATP. For example, the energy supply ratio can reflect how much of the body's energy comes from carbohydrates and how much from fat. In other words, it indicates how much ATP comes from fat and how much from glucose.
[0103] In some examples, after obtaining the concentration of the first portion of multiple target metabolites, the reduction term related to the energy supply of the target metabolites in the corresponding differential kinetic equations can be determined based on the concentration of the first portion of multiple target metabolites (e.g., Figure 4The value of the term corresponding to the arrow pointing to ATP (i.e., the first path D1) is taken as the consumption rate when a target metabolite is converted into ATP. The energy supply ratio is determined based on the ratio of the consumption rate of glucose to the consumption rate of the target metabolite considered as fat. For example, after obtaining the concentration of the first part of multiple target metabolites, the consumption rate when the corresponding target metabolite is converted into ATP can be obtained by substituting the reduction terms related to the energy supply of the target metabolite into the differential kinetic equation.
[0104] Furthermore, since glucose's primary source is carbohydrates, the energy ratio of glucose to fat can also be considered as the energy ratio of carbohydrates to fat.
[0105] In some examples, the concentration of the first part of multiple target metabolites may include blood ketone concentration, muscle free fatty acid concentration, and muscle glucose concentration.
[0106] In some examples, the target metabolites considered as fat may include blood ketones and muscle free fatty acids, and the rate of consumption of these target metabolites can be the sum of the rates of consumption of blood ketones and muscle free fatty acids. In this case, considering both the rates of consumption of blood ketones and muscle free fatty acids simultaneously can improve the accuracy of estimating the rate of fat consumption.
[0107] In some examples, at least one of the proportion of glucose and fat in the body's energy supply can be estimated based on the energy supply ratio. That is, the proportion of glucose and / or fat in the body's energy consumption can be estimated based on the energy supply ratio.
[0108] In some examples, the estimation method may not include step S104, in which case the estimation method may also be called a method for estimating metabolite concentrations based on glucose and ketone bodies.
[0109] Furthermore, after obtaining the energy supply ratio, the mass of glucose and / or fat can be obtained by combining it with the total energy consumed, and the fat-burning rate can be calculated by combining it with time. Therefore, examples of this disclosure also provide a method for determining the fat-burning rate based on glucose and ketone bodies (hereinafter referred to as the determination method). The determination method involved in the examples of this disclosure can also be called a fat-burning rate estimation method. The determination method can be implemented by at least a portion of the components in a computing device. For example, the determination method can be implemented by the processor of processing device 1. It should be noted that, unless there is a contradiction, the above description regarding the estimation method of the energy supply ratio also applies to the determination method.
[0110] Figure 6 This is an exemplary flowchart illustrating the determination method involved in the examples of this disclosure. Figure 7 This is an exemplary flowchart illustrating the determination of fat-burning rate as described in this disclosure.
[0111] refer to Figure 6 In some examples, the determination method may include determining the energy supply ratio at a single time point (step S301) and determining the fat-burning rate based on multiple total energy consumptions at multiple time points and multiple energy supply ratios at multiple time points (step S302). The energy supply ratio at a single time point is determined according to the estimation method involved in the examples of this disclosure.
[0112] In some examples, in step S302, the fat mass at multiple time points can be determined based on the total energy consumed at multiple time points and the energy supply ratio at multiple time points, and the fat burning rate can be determined based on the fat mass at multiple time points.
[0113] In some examples, total energy expenditure at a single time point can be estimated based on heart rate. This improves the ease of obtaining total energy expenditure. In other examples, total energy expenditure at a single time point can be estimated based on heart rate, age, and weight. This improves the accuracy of total energy expenditure estimation.
[0114] In some examples, multiple time points may include a first time point and a second time point. In some examples, reference... Figure 7 Determining the fat-burning rate can include:
[0115] Step S401: Determine the fat mass at the first time point (hereinafter referred to as the first fat mass) based on the total energy consumed and the energy supply ratio at the first time point. Specifically, the energy consumed corresponding to fat can be obtained based on the total energy consumed and the energy supply ratio. The fat mass can be obtained based on the conversion relationship between unit mass of fat and energy (for example, 1 gram of fat can be converted into 9 kilocalories (kcal) of energy) and the energy consumed.
[0116] Step S402: Determine the fat mass at the second time point (hereinafter referred to as the second fat mass) based on the total energy consumed at the second time point and the energy supply ratio at the second time point.
[0117] Step S403: Determine the fat-burning rate based on the first fat mass, the second fat mass, and the time difference between the first and second time points. In some examples, the fat-burning rate can be the difference between the first and second fat masses divided by the time difference.
[0118] Alternatively, a method similar to that used for fat burning rate can be used to calculate glucose consumption rate, which will not be elaborated here.
[0119] Furthermore, the proportion of energy supplied by protein is relatively small and stable, at approximately 5%. In some examples, metabolic pathways representing the conversion of protein to ATP can be added to the target metabolic pathway. That is, the target metabolic pathway can include a second pathway representing the conversion of protein to ATP. This allows for the estimation of the energy supply ratio between protein and other energy-supplying target metabolites. Specifically, the types of multiple target metabolites can include alanine.
[0120] Figure 8 This is an exemplary block diagram illustrating an electronic device 8 as described in this disclosure.
[0121] Examples of this disclosure also relate to an electronic device 8, see reference 8 Figure 8 The electronic device 8 may include a processor 801 (e.g., a central processing unit or a graphics processing unit) and a memory 802. The memory 802 may store a computer program that, when executed, implements one or more steps of the estimation or determination methods described above.
[0122] In some examples, memory 802 may include a computer-readable storage medium, which may include, for example, volatile memory and / or non-volatile memory. Volatile memory may include, for example, random access memory (RAM) and / or cache memory, etc. For example, computer-executable instructions may be loaded from memory unit 807 (described later) into random access memory (RAM) to execute computer-executable instructions. Non-volatile memory may include, for example, read-only memory (ROM), hard disk, USB storage, flash memory, etc.
[0123] In some examples, reference Figure 8 The processor 801 and memory 802 can be connected to each other via bus 803. In some examples, the electronic device 8 may also include an input / output interface 804, which can be connected to bus 803. In some examples, the electronic device 8 may also include an input unit 805 (e.g., touch screen, keyboard, mouse, camera, microphone, etc.), an output unit 806 (e.g., display, speaker, etc.), a storage unit 807 (e.g., magnetic tape, hard disk, flash memory, etc.), and / or a communication unit 808, which can be connected to the input / output interface 804. Additionally, the communication unit 808 can be used to enable the electronic device 8 to communicate wirelessly or wiredly with other electronic devices.
[0124] Examples of this disclosure also disclose a computer-readable storage medium that can store at least one instruction, which, when executed by a processor, implements one or more steps of the estimation or determination methods described above. The computer-readable storage medium can be, but is not limited to, any type of disk, including floppy disks, optical disks, DVDs, CD-ROMs, microdrives, and magneto-optical disks, ROMs, RAMs, EPROMs, EEPROMs, DRAMs, VRAMs, flash memory devices, magnetic cards or optical cards, nanosystems (including molecular memory ICs), or any type of medium or device suitable for storing instructions and / or data.
[0125] While the present disclosure has been specifically described above in conjunction with the accompanying drawings and examples, it is to be understood that the foregoing description does not limit the present disclosure in any way. Those skilled in the art can make modifications and variations to the present disclosure as needed without departing from its essential spirit and scope, and all such modifications and variations shall fall within the scope of the present disclosure.
Claims
1. A method for estimating the energy supply ratio based on glucose and ketone bodies, characterized in that, include: A metabolic model based on a target metabolic pathway is established, the target metabolic pathway including a first pathway representing the conversion of glucose and fat into ATP, the metabolic model being used to represent the relationship between multiple target metabolites associated with the target metabolic pathway; glucose concentration and ketone body concentration are obtained and measured, the measured glucose concentration and the measured ketone body concentration representing the blood glucose concentration and ketone body concentration in different tissues distributed by the target metabolic pathway, respectively, the multiple target metabolites including blood glucose and ketone bodies; based on the measured glucose concentration, the measured ketone body concentration and the metabolic model, the concentration of a first portion of the multiple target metabolites is estimated, the first portion of the multiple target metabolites being the target metabolites other than ATP in the first pathway; and the energy supply ratio of glucose and fat is determined based on the concentration of the first portion of the multiple target metabolites.
2. The method according to claim 1, characterized in that, The metabolic model is a kinetic model, where the concentrations of the second portion, including the first portion, of the plurality of target metabolites are defined as multiple state variables of the metabolic model, each state variable representing the concentration of a target metabolite. Based on the metabolic model, the multiple state variables are evolved to estimate the concentration of the second portion of the plurality of target metabolites, thereby obtaining the concentration of the first portion of the plurality of target metabolites. The measured glucose concentration is used as input to drive the evolution of the multiple state variables, and the measured ketone body concentration is used as a response to calibrate the evolution of the multiple state variables.
3. The method according to claim 2, characterized in that, An initial state vector is created, comprising initial values of the plurality of state variables; based on the initial state vector, the metabolic model is simulated to obtain an evolutionary state vector by inputting the initial state vector and the measured glucose concentration to the plurality of state variables; based on the measured ketone body concentration, the evolutionary state vector is calibrated using a Kalman filter, wherein the measured value of the Kalman filter is the measured ketone body concentration, and the predicted value of the Kalman filter is the estimated blood ketone body concentration based on the evolutionary state vector.
4. The method according to claim 2, characterized in that, The metabolic model comprises multiple differential kinetic equations, each representing the rate of change of a target metabolite and based on the aforementioned relationship. Each differential kinetic equation is linear. Each differential kinetic equation includes multiple terms that increase and / or decrease the rate of change of the target metabolite, wherein, in response to the aforementioned relationship between the rate of change of the target metabolite and blood glucose, the multiple terms include terms related to the measured glucose concentration, and in response to the conversion relationship between the target metabolite and ATP, the multiple terms include a decreasing term related to the energy supply of the target metabolite.
5. The method according to claim 4, characterized in that, The value of the reduction term related to the energy supply of the target metabolite in the corresponding differential kinetic equation is determined based on the concentration of the first portion of the multiple target metabolites, and is used as the consumption rate when the target metabolite is converted into ATP; the energy supply ratio is determined based on the ratio of the consumption rate of glucose to the consumption rate of the target metabolite considered as fat.
6. The method according to claim 5, characterized in that, The target metabolites considered as fat include ketone bodies in the blood and free fatty acids in the muscle, and the consumption rate of the target metabolites considered as fat is the sum of the consumption rates of ketone bodies in the blood and free fatty acids in the muscle.
7. The method according to claim 2, characterized in that, The different tissues also include at least one of the liver, muscle, fat cells, and brain cells, and the multiple state variables include at least one of liver glycogen, liver free fatty acids, liver triglycerides, blood free fatty acids, blood ketones, blood triglycerides, muscle glycogen, muscle glucose, muscle free fatty acids, muscle triglycerides, and insulin in the body.
8. A method for determining fat-burning rate based on glucose and ketone bodies, characterized in that, include: The method according to any one of claims 1 to 7 determines the energy supply ratio at a single time point; Furthermore, the fat-burning rate is determined based on the total energy consumption at multiple time points and the energy supply ratio at multiple time points.
9. The method according to claim 8, characterized in that, The plurality of time points includes a first time point and a second time point. Determining the fat-burning rate includes: determining the fat mass at the first time point based on the total energy consumed at the first time point and the energy supply ratio at the first time point; determining the fat mass at the second time point based on the total energy consumed at the second time point and the energy supply ratio at the second time point; and determining the fat-burning rate based on the fat mass at the first time point, the fat mass at the second time point, and the time difference between the first time point and the second time point.
10. An electronic device, characterized in that, It includes a processor and a memory, the memory storing a computer program that, when executed, implements the method as claimed in any one of claims 1 to 7 or the method as claimed in any one of claims 8 to 9.
